49 related articles for article (PubMed ID: 6337213)
1. The role of interleukin-1 in the pathogenesis of IDDM.
Mandrup-Poulsen T
Diabetologia; 1996 Sep; 39(9):1005-29. PubMed ID: 8877284
[No Abstract] [Full Text] [Related]
2. Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity.
Maruyama T; Takei I; Taniyama M; Kataoka K; Matsuki S
Diabetologia; 1984 Jul; 27 Suppl():121-3. PubMed ID: 6383915
[TBL] [Abstract][Full Text] [Related]
3. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
[TBL] [Abstract][Full Text] [Related]
4. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
[TBL] [Abstract][Full Text] [Related]
5. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.
Drell DW; Notkins AL
Diabetologia; 1987 Mar; 30(3):132-43. PubMed ID: 3556288
[No Abstract] [Full Text] [Related]
6. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.
Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles MA
Diabetologia; 1986 Jun; 29(6):352-7. PubMed ID: 3527835
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.
MacKay P; Jacobson J; Rabinovitch A
J Clin Invest; 1986 Mar; 77(3):916-24. PubMed ID: 3512604
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin-dependent) diabetes mellitus.
Lohmann D; Krug J; Lampeter EF; Bierwolf B; Verlohren HJ
Diabetologia; 1986 Jul; 29(7):421-5. PubMed ID: 2943624
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility complex protein expression on pancreas and pancreatic islet endocrine cell subsets.
Lautenschlager I; Inkinen K; Taskinen E; Charles MA; Hayry P
Am J Pathol; 1989 Dec; 135(6):1129-37. PubMed ID: 2688432
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.
Nair MP; Lewis EW; Schwartz SA
J Clin Immunol; 1986 Sep; 6(5):363-72. PubMed ID: 2429979
[TBL] [Abstract][Full Text] [Related]
11. Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.
Krug J; Bierwolf B; Lampeter E; Verlohren HJ; Lohmann D
Clin Exp Immunol; 1991 Apr; 84(1):43-7. PubMed ID: 1826646
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
[TBL] [Abstract][Full Text] [Related]
13. Immunological events in new onset diabetes.
Charles M; Suzuki M; Sundsmo J; Waldeck N; Negishi K; Slater L; Ong K; Buckingham B; Kershnar A
Biomed Biochim Acta; 1984; 43(5):615-9. PubMed ID: 6383365
[TBL] [Abstract][Full Text] [Related]
14. Immunological aspects of diabetes.
Cheţa D
Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
Ohanian SH; Schlager SI
Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
[TBL] [Abstract][Full Text] [Related]
16. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell and islet killer cell activities in human type 1 diabetes.
Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles AM
Exp Clin Endocrinol; 1987 Aug; 89(3):345-53. PubMed ID: 3311777
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
